Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SAVA |
---|---|---|
09:32 ET | 18970 | 27.27 |
09:34 ET | 1858 | 27.1651 |
09:36 ET | 17086 | 26.875 |
09:38 ET | 5395 | 26.8273 |
09:39 ET | 12155 | 26.65 |
09:41 ET | 9406 | 26.66 |
09:43 ET | 12636 | 26.6565 |
09:45 ET | 6557 | 26.6361 |
09:48 ET | 11302 | 26.85 |
09:50 ET | 9904 | 27.125 |
09:52 ET | 7776 | 26.9831 |
09:54 ET | 2869 | 26.9 |
09:56 ET | 8430 | 26.82 |
09:57 ET | 3356 | 26.8925 |
09:59 ET | 7782 | 26.86 |
10:01 ET | 4605 | 26.805 |
10:03 ET | 1764 | 26.9 |
10:06 ET | 5366 | 26.955 |
10:08 ET | 5271 | 26.875 |
10:10 ET | 400 | 26.9 |
10:12 ET | 3510 | 26.9598 |
10:14 ET | 8039 | 26.87 |
10:15 ET | 3101 | 26.95 |
10:17 ET | 3270 | 26.875 |
10:19 ET | 350 | 27 |
10:21 ET | 4039 | 27.01 |
10:24 ET | 4362 | 26.82 |
10:26 ET | 2907 | 26.9067 |
10:28 ET | 2355 | 27.0102 |
10:30 ET | 2400 | 27 |
10:32 ET | 3890 | 27.11 |
10:33 ET | 14980 | 27.5 |
10:35 ET | 5162 | 27.53 |
10:37 ET | 7389 | 27.355 |
10:39 ET | 2808 | 27.4 |
10:42 ET | 971 | 27.44 |
10:44 ET | 4570 | 27.49 |
10:46 ET | 2153 | 27.49 |
10:48 ET | 3852 | 27.41 |
10:50 ET | 1532 | 27.48 |
10:51 ET | 16147 | 27.55 |
10:53 ET | 12778 | 27.43 |
10:55 ET | 6560 | 27.34 |
10:57 ET | 1400 | 27.35 |
11:00 ET | 2518 | 27.37 |
11:02 ET | 1405 | 27.32 |
11:04 ET | 775 | 27.4 |
11:06 ET | 4277 | 27.51 |
11:08 ET | 3506 | 27.46 |
11:09 ET | 3275 | 27.35 |
11:11 ET | 1748 | 27.395 |
11:13 ET | 4511 | 27.2858 |
11:15 ET | 7328 | 27.13 |
11:18 ET | 1100 | 27.107 |
11:20 ET | 2445 | 27.11 |
11:22 ET | 800 | 27.1041 |
11:24 ET | 262 | 27.1517 |
11:26 ET | 500 | 27.14 |
11:27 ET | 2608 | 27.14 |
11:29 ET | 1080 | 27.1435 |
11:31 ET | 1500 | 27.0893 |
11:33 ET | 200 | 27.18 |
11:36 ET | 400 | 27.2 |
11:38 ET | 2520 | 27.25 |
11:40 ET | 3561 | 27.21 |
11:42 ET | 3966 | 27.18 |
11:44 ET | 362 | 27.15 |
11:45 ET | 1110 | 27.19 |
11:47 ET | 200 | 27.2 |
11:49 ET | 1030 | 27.2105 |
11:51 ET | 1366 | 27.2 |
11:54 ET | 400 | 27.13 |
11:56 ET | 1964 | 27.185 |
11:58 ET | 4277 | 27.125 |
12:00 ET | 2882 | 27.16 |
12:02 ET | 1550 | 27.12 |
12:03 ET | 3100 | 27.1 |
12:05 ET | 1670 | 27.27 |
12:07 ET | 700 | 27.295 |
12:09 ET | 3249 | 27.33 |
12:12 ET | 4101 | 27.23 |
12:14 ET | 1922 | 27.13 |
12:16 ET | 1700 | 27.125 |
12:18 ET | 18758 | 27.01 |
12:20 ET | 13173 | 26.89 |
12:21 ET | 2360 | 26.98 |
12:23 ET | 7858 | 26.95 |
12:25 ET | 3278 | 27 |
12:27 ET | 5098 | 27 |
12:30 ET | 400 | 27.02 |
12:32 ET | 700 | 26.95 |
12:34 ET | 1325 | 26.97 |
12:36 ET | 3402 | 26.975 |
12:38 ET | 1255 | 27 |
12:39 ET | 1122 | 27 |
12:41 ET | 1979 | 26.95 |
12:43 ET | 1500 | 26.81 |
12:45 ET | 1650 | 26.8287 |
12:48 ET | 3426 | 26.8599 |
12:50 ET | 3706 | 26.875 |
12:52 ET | 1747 | 26.79 |
12:54 ET | 400 | 26.828 |
12:56 ET | 14753 | 26.83 |
12:57 ET | 8207 | 26.8 |
12:59 ET | 1000 | 26.84 |
01:01 ET | 600 | 26.78 |
01:03 ET | 746 | 26.835 |
01:06 ET | 3040 | 26.81 |
01:08 ET | 200 | 26.79 |
01:10 ET | 12146 | 26.725 |
01:12 ET | 2888 | 26.76 |
01:14 ET | 1050 | 26.78 |
01:15 ET | 858 | 26.82 |
01:17 ET | 8407 | 26.84 |
01:19 ET | 650 | 26.8 |
01:21 ET | 3075 | 26.743 |
01:24 ET | 1490 | 26.7859 |
01:28 ET | 1800 | 26.8098 |
01:30 ET | 10490 | 26.86 |
01:32 ET | 2706 | 26.74 |
01:33 ET | 612 | 26.78 |
01:35 ET | 950 | 26.78 |
01:37 ET | 215 | 26.765 |
01:39 ET | 1000 | 26.8 |
01:42 ET | 2001 | 26.8043 |
01:44 ET | 8992 | 26.8317 |
01:46 ET | 100 | 26.8 |
01:48 ET | 2233 | 26.87 |
01:50 ET | 4020 | 26.8772 |
01:51 ET | 3598 | 26.8 |
01:53 ET | 16825 | 26.81 |
01:55 ET | 1704 | 26.78 |
01:57 ET | 3759 | 26.88 |
02:00 ET | 2330 | 26.955 |
02:02 ET | 5286 | 26.97 |
02:04 ET | 1900 | 26.98 |
02:06 ET | 11368 | 26.93 |
02:08 ET | 3036 | 26.945 |
02:09 ET | 100 | 26.95 |
02:11 ET | 2780 | 26.875 |
02:13 ET | 3731 | 27.03 |
02:15 ET | 3100 | 26.9931 |
02:18 ET | 1644 | 27.0192 |
02:20 ET | 12712 | 27.01 |
02:22 ET | 1986 | 26.9848 |
02:24 ET | 300 | 26.95 |
02:27 ET | 472 | 26.93 |
02:29 ET | 1050 | 26.8781 |
02:31 ET | 2654 | 26.9899 |
02:33 ET | 3030 | 27.03 |
02:36 ET | 2654 | 27.0297 |
02:38 ET | 2509 | 26.98 |
02:40 ET | 3100 | 26.9501 |
02:42 ET | 100 | 26.982 |
02:44 ET | 1221 | 27.0557 |
02:45 ET | 800 | 27.055 |
02:47 ET | 4566 | 27.067 |
02:49 ET | 800 | 27.09 |
02:51 ET | 1500 | 27.07 |
02:54 ET | 1337 | 27.05 |
02:56 ET | 972 | 27.0283 |
02:58 ET | 400 | 27.03 |
03:00 ET | 2400 | 27.09 |
03:02 ET | 1800 | 27.13 |
03:03 ET | 1700 | 27.05 |
03:05 ET | 800 | 27.06 |
03:07 ET | 656 | 27.06 |
03:09 ET | 1800 | 27.09 |
03:12 ET | 100 | 27.06 |
03:14 ET | 248 | 27.09 |
03:18 ET | 1565 | 27.0401 |
03:20 ET | 875 | 27.03 |
03:21 ET | 2420 | 27.07 |
03:25 ET | 3134 | 27.09 |
03:27 ET | 600 | 27.061 |
03:30 ET | 1308 | 27.0482 |
03:32 ET | 3241 | 26.97 |
03:34 ET | 780 | 26.965 |
03:36 ET | 2700 | 26.97 |
03:38 ET | 2159 | 26.98 |
03:39 ET | 7549 | 26.9413 |
03:41 ET | 524 | 26.99 |
03:43 ET | 10140 | 26.88 |
03:45 ET | 2759 | 27.02 |
03:48 ET | 2724 | 26.91 |
03:50 ET | 819 | 26.9 |
03:52 ET | 7337 | 26.83 |
03:54 ET | 4753 | 26.835 |
03:56 ET | 32612 | 26.85 |
03:57 ET | 13908 | 26.88 |
03:59 ET | 50421 | 26.94 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cassava Sciences Inc | 1.3B | -66.4x | --- |
Spyre Therapeutics Inc | 1.4B | -1.8x | --- |
ARS Pharmaceuticals Inc | 1.4B | -31.0x | --- |
Day One Biopharmaceuticals Inc | 1.2B | -7.0x | --- |
Enliven Therapeutics Inc | 1.2B | -13.1x | --- |
Tyra Biosciences Inc | 1.2B | -13.2x | --- |
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.59 |
EPS | $-0.41 |
Book Value | $3.25 |
P/E Ratio | -66.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.